BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 11259560)

  • 1. Application of the relative activity factor approach in scaling from heterologously expressed cytochromes p450 to human liver microsomes: studies on amitriptyline as a model substrate.
    Venkatakrishnan K; von Moltke LL; Greenblatt DJ
    J Pharmacol Exp Ther; 2001 Apr; 297(1):326-37. PubMed ID: 11259560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches.
    Venkatakrishnan K; von Moltke LL; Court MH; Harmatz JS; Crespi CL; Greenblatt DJ
    Drug Metab Dispos; 2000 Dec; 28(12):1493-504. PubMed ID: 11095589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reappraisal of human CYP isoforms involved in imipramine N-demethylation and 2-hydroxylation: a study using microsomes obtained from putative extensive and poor metabolizers of S-mephenytoin and eleven recombinant human CYPs.
    Koyama E; Chiba K; Tani M; Ishizaki T
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1199-210. PubMed ID: 9190854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scaling drug biotransformation data from cDNA-expressed cytochrome P-450 to human liver: a comparison of relative activity factors and human liver abundance in studies of mirtazapine metabolism.
    Störmer E; von Moltke LL; Greenblatt DJ
    J Pharmacol Exp Ther; 2000 Nov; 295(2):793-801. PubMed ID: 11046120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five distinct human cytochromes mediate amitriptyline N-demethylation in vitro: dominance of CYP 2C19 and 3A4.
    Venkatakrishnan K; Greenblatt DJ; von Moltke LL; Schmider J; Harmatz JS; Shader RI
    J Clin Pharmacol; 1998 Feb; 38(2):112-21. PubMed ID: 9549641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diazinon, chlorpyrifos and parathion are metabolised by multiple cytochromes P450 in human liver.
    Mutch E; Williams FM
    Toxicology; 2006 Jul; 224(1-2):22-32. PubMed ID: 16757081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative contribution of CYP3A to amitriptyline clearance in humans: in vitro and in vivo studies.
    Venkatakrishnan K; Schmider J; Harmatz JS; Ehrenberg BL; von Moltke LL; Graf JA; Mertzanis P; Corbett KE; Rodriguez MC; Shader RI; Greenblatt DJ
    J Clin Pharmacol; 2001 Oct; 41(10):1043-54. PubMed ID: 11583471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolism of the piperazine-type phenothiazine neuroleptic perazine by the human cytochrome P-450 isoenzymes.
    Wójcikowski J; Pichard-Garcia L; Maurel P; Daniel WA
    Eur Neuropsychopharmacol; 2004 May; 14(3):199-208. PubMed ID: 15056479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of human liver microsomal oxidations of 7-ethoxycoumarin and chlorzoxazone with kinetic parameters of recombinant cytochrome P-450 enzymes.
    Shimada T; Tsumura F; Yamazaki H
    Drug Metab Dispos; 1999 Nov; 27(11):1274-80. PubMed ID: 10534312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P-450 profiles.
    Roy P; Yu LJ; Crespi CL; Waxman DJ
    Drug Metab Dispos; 1999 Jun; 27(6):655-66. PubMed ID: 10348794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro metabolism study of buprenorphine: evidence for new metabolic pathways.
    Picard N; Cresteil T; Djebli N; Marquet P
    Drug Metab Dispos; 2005 May; 33(5):689-95. PubMed ID: 15743975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterologous expression and kinetic characterization of human cytochromes P-450: validation of a pharmaceutical tool for drug metabolism research.
    Masimirembwa CM; Otter C; Berg M; Jönsson M; Leidvik B; Jonsson E; Johansson T; Bäckman A; Edlund A; Andersson TB
    Drug Metab Dispos; 1999 Oct; 27(10):1117-22. PubMed ID: 10497136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of intersystem extrapolation factors in early reaction phenotyping and the quantitative extrapolation of human liver microsomal intrinsic clearance using recombinant cytochromes P450.
    Chen Y; Liu L; Nguyen K; Fretland AJ
    Drug Metab Dispos; 2011 Mar; 39(3):373-82. PubMed ID: 21148079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro biotransformation of sildenafil (Viagra): identification of human cytochromes and potential drug interactions.
    Warrington JS; Shader RI; von Moltke LL; Greenblatt DJ
    Drug Metab Dispos; 2000 Apr; 28(4):392-7. PubMed ID: 10725306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of human cytochrome P-450 isoforms involved in metabolism of R(+)- and S(-)-gallopamil: utility of in vitro disappearance rate.
    Suzuki A; Iida I; Tanaka F; Akimoto M; Fukushima K; Tani M; Ishizaki T; Chiba K
    Drug Metab Dispos; 1999 Nov; 27(11):1254-9. PubMed ID: 10534309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major pathway of imipramine metabolism is catalyzed by cytochromes P-450 1A2 and P-450 3A4 in human liver.
    Lemoine A; Gautier JC; Azoulay D; Kiffel L; Belloc C; Guengerich FP; Maurel P; Beaune P; Leroux JP
    Mol Pharmacol; 1993 May; 43(5):827-32. PubMed ID: 8502233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P-450 isoforms involved in carboxylic acid ester cleavage of Hantzsch pyridine ester of pranidipine.
    Kudo S; Okumura H; Miyamoto G; Ishizaki T
    Drug Metab Dispos; 1999 Feb; 27(2):303-8. PubMed ID: 9929520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of a dry extract from milk thistle (Silybum marianum) for interference with human liver cytochrome-P450 activities.
    Doehmer J; Weiss G; McGregor GP; Appel K
    Toxicol In Vitro; 2011 Feb; 25(1):21-7. PubMed ID: 20828605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic activation of the potent carcinogen dibenzo[a,h]anthracene by cDNA-expressed human cytochromes P450.
    Shou M; Krausz KW; Gonzalez FJ; Gelboin HV
    Arch Biochem Biophys; 1996 Apr; 328(1):201-7. PubMed ID: 8638931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites.
    Avent KM; DeVoss JJ; Gillam EM
    Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.